Pursuant to Regulation 34(1) of the Listing Regulations, Kopran has submitted the Annual Report of the Company for Financial Year 2020-21 to the exchange. The 62nd Annual General Meeting of the Company will be held on Tuesday, 31st August 2021 at 12.30 pm (IST) via video conferencing ('VC')/other audio-visual means ('OAVM'). The e-mail communication of the Notice to the 62nd AGM shall be dispatched through NSDL from 3rd August 2021 onwards. The Annual Report for the Financial Year 2020-21 can be accessed through electronic mode at: http://kopran.com/investors/financials/pdf/Kopran%20Limited%20AR%202020-21.pdf.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: